Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients

Assessing the Expressions of Ezrin, Phosphorylated Ezrin, and Pip5k1α in the Airway Smooth Muscle of Asthmatic Patient

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Asthma, a prevalent chronic respiratory affliction, significantly impinges upon the quality of life for affected individuals. Timely and appropriate diagnostic measures, coupled with efficacious therapeutic interventions, are paramount in mitigating exacerbations of symptoms and enhancing the life quality of patients. Ezrin plays an important role in maintaining cell morphology, cell migration, cell adhesion and polarisation, but Ezrin expression in airway smooth muscle remains unclear. Pip5k1α is an important kinase involved in intracellular phosphatidylinositol signalling pathways that may be involved in smooth muscle contraction and diastole. Therefore, further studies are necessary to elucidate the changes of Ezrin and Pip5k1α in patients with asthma to provide a basis for investigating alternative treatments for asthma.

Who May Be Eligible (Plain English)

Who May Qualify: - Lung tissue samples; - The samples come from patients aged 18-70 years old, regardless of gender, who underwent lung tissue sampling for surgical indications during treatment; - Paraffin sections of lung tissue from patients diagnosed with bronchial asthma, including tracheal smooth muscle; - Paraffin sections of lung tissue from non-asthma patients, including tracheal smooth muscle. Who Should NOT Join This Trial: - Paraffin sections of lung tissue from patients who have been diagnosed with COPD; - Other situations where the researcher deems it inappropriate to participate in this study. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Lung tissue samples; * The samples come from patients aged 18-70 years old, regardless of gender, who underwent lung tissue sampling for surgical indications during treatment; * Paraffin sections of lung tissue from patients diagnosed with bronchial asthma, including tracheal smooth muscle; * Paraffin sections of lung tissue from non-asthma patients, including tracheal smooth muscle. Exclusion Criteria: * Paraffin sections of lung tissue from patients who have been diagnosed with COPD; * Other situations where the researcher deems it inappropriate to participate in this study.

Treatments Being Tested

OTHER

No intervention.

Observational study with no intervention.

Locations (1)

Yueyang Hospital, Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China